Dengue takes life of a 45-yr old AIIMS staffer

Published On 2015-09-11 04:35 GMT   |   Update On 2015-09-11 04:35 GMT
Advertisement
The dengue toll in Delhi has reached three this year, with a 45-yr old AIIMS staffer recently reported to have died because of the mosquito-borne disease.

Balwan, was a resident of west Delhi working as an attendant in the AIIMS director's office. He was admitted to the hospital on September 3 following the initial symptoms of severe fever and vomiting. He later succumbed to the situation. A doctor at the All India Institute of Medical Sciences confirmed that the patient was suffering from dengue.

"Initially, he had come with multiple organ dysfunction syndrome (MODS), secondary to dengue. But two days ago, he tested for dengue also," the doctor told IANS.

"Though he was in the ICU, his condition deteriorated and he succumbed to the disease today (Thursday) morning," he added.

Delhi has witnessed 1,259 dengue cases till September 5.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News